NEW YORK, June 13, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CarGurus, Inc. (NASDAQ: CARG ), ArcelorMittal (NYSE: MT ), Capricor Therapeutics, Inc. (NASDAQ: CAPR ), B&G Foods, Inc. (NYSE: BGS ), Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ), and Photronics, Inc. (NASDAQ: PLAB ), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
CARG DOWNLOAD: http://Fundamental-Markets.com/register/?so=CARG MT DOWNLOAD: http://Fundamental-Markets.com/register/?so=MT CAPR DOWNLOAD: http://Fundamental-Markets.com/register/?so=CAPR BGS DOWNLOAD: http://Fundamental-Markets.com/register/?so=BGS IONS DOWNLOAD: http://Fundamental-Markets.com/register/?so=IONS PLAB DOWNLOAD: http://Fundamental-Markets.com/register/?so=PLAB
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine CarGurus, Inc. (NASDAQ: CARG ), ArcelorMittal (NYSE: MT ), Capricor Therapeutics, Inc. (NASDAQ: CAPR ), B&G Foods, Inc. (NYSE: BGS ), Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ), and Photronics, Inc. (NASDAQ: PLAB ) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed June 11th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
CARGURUS, INC. (CARG) REPORT OVERVIEW
CarGurus' Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, CarGurus reported revenue of $98.70MM vs $67.04MM (up 47.24%) and basic earnings per share $0.03 vs $0.04 (down 25.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, CarGurus reported revenue of $316.86MM vs $198.14MM (up 59.92%) and basic earnings per share $0.13 vs -$0.58. CarGurus is expected to report earnings on August 2nd, 2018. The report will be for the fiscal period ending June 30th, 2018. The estimated EPS forecast for the next fiscal year is $0.13 and is expected to report on March 7th, 2019.
To read the full CarGurus, Inc. (CARG) report, download it here: http://Fundamental-Markets.com/register/?so=CARG
-----------------------------------------
ARCELORMITTAL (MT) REPORT OVERVIEW
ArcelorMittal's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, ArcelorMittal reported revenue of $19,186.00MM vs $16,086.00MM (up 19.27%) and basic earnings per share $1.17 vs $0.98 (up 19.39%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, ArcelorMittal reported revenue of $68,679.00MM vs $56,791.00MM (up 20.93%) and basic earnings per share $4.48 vs $1.87 (up 139.57%). ArcelorMittal is expected to report earnings on July 26th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $1.33. The estimated EPS forecast for the next fiscal year is $4.60 and is expected to report on January 30th, 2019.
To read the full ArcelorMittal (MT) report, download it here: http://Fundamental-Markets.com/register/?so=MT
-----------------------------------------
CAPRICOR THERAPEUTICS, INC. (CAPR) REPORT OVERVIEW
Capricor Therapeutics' Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Capricor Therapeutics reported revenue of $0.40MM vs $0.88MM (down 54.58%) and basic earnings per share -$0.14 vs -$0.17. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Capricor Therapeutics reported revenue of $2.67MM vs $4.00MM (down 33.32%) and basic earnings per share $0.10 vs -$1.01. Capricor Therapeutics is expected to report earnings on August 9th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.16. The estimated EPS forecast for the next fiscal year is -$0.44 and is expected to report on March 13th, 2019.
To read the full Capricor Therapeutics, Inc. (CAPR) report, download it here: http://Fundamental-Markets.com/register/?so=CAPR
-----------------------------------------
B&G FOODS, INC. (BGS) REPORT OVERVIEW
B&G Foods' Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, B&G Foods reported revenue of $431.73MM vs $412.31MM (up 4.71%) and basic earnings per share $0.31 vs $0.49 (down 36.73%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, B&G Foods reported revenue of $1,668.06MM vs $1,391.26MM (up 19.90%) and basic earnings per share $3.27 vs $1.73 (up 89.02%). B&G Foods is expected to report earnings on August 2nd, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.41. The estimated EPS forecast for the next fiscal year is $2.30 and is expected to report on February 26th, 2019.
To read the full B&G Foods, Inc. (BGS) report, download it here: http://Fundamental-Markets.com/register/?so=BGS
-----------------------------------------
IONIS PHARMACEUTICALS, INC. (IONS) REPORT OVERVIEW
Ionis Pharmaceuticals' Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Ionis Pharmaceuticals reported revenue of $144.42MM vs $115.80MM (up 24.71%) and basic earnings per share -$0.01 vs $0.07. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Ionis Pharmaceuticals reported revenue of $507.67MM vs $346.62MM (up 46.46%) and basic earnings per share $0.08 vs -$0.72. Ionis Pharmaceuticals is expected to report earnings on August 14th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.09. The estimated EPS forecast for the next fiscal year is $0.35 and is expected to report on February 26th, 2019.
To read the full Ionis Pharmaceuticals, Inc. (IONS) report, download it here: http://Fundamental-Markets.com/register/?so=IONS
-----------------------------------------
PHOTRONICS, INC. (PLAB) REPORT OVERVIEW
Photronics' Recent Financial Performance
For the three months ended April 30th, 2018 vs April 30th, 2017, Photronics reported revenue of $130.78MM vs $108.30MM (up 20.76%) and basic earnings per share $0.15 vs $0.03 (up 400.00%). For the twelve months ended October 31st, 2017 vs October 31st, 2016, Photronics reported revenue of $450.68MM vs $483.46MM (down 6.78%) and basic earnings per share $0.19 vs $0.68 (down 72.06%). Photronics is expected to report earnings on August 13th, 2018. The report will be for the fiscal period ending July 31st, 2018. The reported EPS for the same quarter last year was $0.06. The estimated EPS forecast for the next fiscal year is $0.43 and is expected to report on December 5th, 2018.
To read the full Photronics, Inc. (PLAB) report, download it here: http://Fundamental-Markets.com/register/?so=PLAB
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
